Pregnancy: Maternal and Fetal Heart Disease

Current Problems in Cardiology

Volumn 32, Issue 8, 2007, Pages 419-494

  Hameed, Afshan B ^a   Sklansky, Mark S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANAMNESIS; ARTICLE; CARDIOLOGIST; CONGENITAL HEART DISEASE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FETUS DISEASE; FETUS HEART; FETUS OUTCOME; HEART DISEASE; HUMAN; MATERNAL CARE; MATERNAL DISEASE; MEDICAL SPECIALIST; NEWBORN MORBIDITY; NEWBORN MORTALITY; PATIENT COUNSELING; PHYSICAL EXAMINATION; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL SCREENING; THORAX RADIOGRAPHY;

CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; DELIVERY, OBSTETRIC; FEMALE; FETAL DISEASES; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PRENATAL DIAGNOSIS; RISK FACTORS;

EID: 34447570645     PISSN: 01462806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cpcardiol.2007.04.004     Document Type: Article

References (224)

1. Otterson W.N., and Dunnihoo D.R. In: Pauerstein C.J. (Ed). Cardiac disease (2005), John Wiley & Sons, New York 627-644
2. Ueland K., and Metcalfe J. Circulatory changes in pregnancy. Clin Obstet Gynecol 18 3 (1975) 41-50
3. Chesley L.C. Cardiovascular changes in pregnancy. Obstet Gynecol Annu 4 (1975) 71-97
4. Longo L.D. Maternal blood volume and cardiac output during pregnancy: a hypothesis of endocrinologic control. Am J Physiol 245 5 Pt 1 (1983) R720-R729
5. Preedy J.R., and Aitken E.H. The effect of estrogen on water and electrolyte metabolism. I. The normal. J Clin Invest 35 4 (1956) 423-429
6. Ferris T.F., Gorden P., and Mulrow P.J. Rabbit uterus as a source of renin. Am J Physiol 212 3 (1967) 698-702
7. Prowse C.M., and Gaensler E.A. Respiratory and acid-base changes during pregnancy. Anesthesiology 26 (1965) 381-392
8. Pernoll M.L., Metcalfe J., Schlenker T.L., et al. Oxygen consumption at rest and during exercise in pregnancy. Respir Physiol 25 3 (1975) 285-293
9. Kjeldsen J. Hemodynamic investigations during labour and delivery. Acta Obstet Gynecol Scand Suppl 89 (1979) 1-252
10. Mabie W.C., DiSessa T.G., Crocker L.G., et al. A longitudinal study of cardiac output in normal human pregnancy. Am J Obstet Gynecol 170 3 (1994) 849-856
11. Kerr M.G. The mechanical effects of the gravid uterus in late pregnancy. J Obstet Gynaecol Br Commonw 72 (1965) 513-529
12. Holmes F. The supine hypotensive syndrome. 1960. Anaesthesia 50 11 (1995) 972-977
13. Kinsella S.M., and Lohmann G. Supine hypotensive syndrome. Obstet Gynecol 83 5 Pt 1 (1994) 774-788
14. Hurst J.W., Staton J., and Hubbard D. Precordial murmurs during pregnancy and lactation. N Engl J Med 259 11 (1958) 515-517
15. O'Rourke R.A., Ewy G.A., Marcus F.I., et al. Cardiac auscultation in pregnancy. Med Ann Dist Columbia 39 2 (1970) 92-94
16. Robson S.C., Hunter S., Boys R.J., et al. Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol 256 4 Pt 2 (1989) H1060-H1065
17. Campos O. Doppler echocardiography during pregnancy: physiological and abnormal findings. Echocardiography 13 2 (1996) 135-146
18. Campos O., Andrade J.L., Bocanegra J., et al. Physiologic multivalvular regurgitation during pregnancy: a longitudinal Doppler echocardiographic study. Int J Cardiol 40 3 (1993) 265-272
19. Robson S.C., Dunlop W., Boys R.J., et al. Cardiac output during labour. Br Med J (Clin Res Ed) 295 6607 (1987) 1169-1172
20. Ueland K., and Hansen J.M. Maternal cardiovascular dynamics. 3. Labor and delivery under local and caudal analgesia. Am J Obstet Gynecol 103 1 (1969) 8-18
21. Henricks C.H., and Quilligan E.J. Cardiac output during labor. Am J Obstet Gynecol 71 (1956) 953-972
22. Bonow R.O., Carabello B., de Leon A.C., et al. ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease. Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease). J Heart Valve Dis 7 6 (1998) 672-707
23. Siu S.C., Sermer M., Harrison D.A., et al. Risk and predictors for pregnancy-related complications in women with heart disease. Circulation 96 9 (1997) 2789-2794
24. Siu S.C., Sermer M., Colman J.M., et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 104 5 (2001) 515-521
25. Szekely P., Turner R., and Snaith L. Pregnancy and the changing pattern of rheumatic heart disease. Br Heart J 35 12 (1973) 1293-1303
26. Hameed A., Karaalp I.S., Tummala P.P., et al. The effect of valvular heart disease on maternal and fetal outcome of pregnancy. J Am Coll Cardiol 37 3 (2001) 893-899
27. Desai D.K., Adanlawo M., Naidoo D.P., et al. Mitral stenosis in pregnancy: a four-year experience at King Edward VIII Hospital, Durban, South Africa. BJOG 107 8 (2000) 953-958
28. Demir I., Yilmaz H., Basarici I., et al. [Prognostic factors of mitral stenosis during pregnancy]. Anadolu Kardiyol Derg 2 3 (2002) 213-217
29. Colman J.M., Sermer M., Seaward P.G., et al. Congenital heart disease in pregnancy. Cardiol Rev 8 3 (2000) 166-173
30. Lao T.T., Adelman A.G., Sermer M., et al. Balloon valvuloplasty for congenital aortic stenosis in pregnancy. Br J Obstet Gynaecol 100 12 (1993) 1141-1142
31. Myerson S.G., Mitchell A.R., Ormerod O.J., et al. What is the role of balloon dilatation for severe aortic stenosis during pregnancy?. J Heart Valve Dis 14 2 (2005) 147-150
32. Lao T.T., Adelman A.G., Sermer M., et al. Balloon valvuloplasty for congenital aortic stenosis in pregnancy. Br J Obstet Gynaecol 100 12 (1993) 1141-1142
33. Mooij P.N., de Jong P.A., Bavinck J.H., et al. Aortic valve replacement in the second trimester of pregnancy: a case report. Eur J Obstet Gynecol Reprod Biol 29 4 (1988) 347-352
34. Nelson D.M., Main E., Crafford W., et al. Peripartum heart failure due to primary pulmonary hypertension. Obstet Gynecol 62 suppl 3 (1983) 58s-63s
35. Penning S., Robinson K.D., Major C.A., et al. A comparison of echocardiography and pulmonary artery catheterization for evaluation of pulmonary artery pressures in pregnant patients with suspected pulmonary hypertension. Am J Obstet Gynecol 184 7 (2001) 1568-1570
36. Easterling T.R., Ralph D.D., and Schmucker B.C. Pulmonary hypertension in pregnancy: treatment with pulmonary vasodilators. Obstet Gynecol 93 4 (1999) 494-498
37. Shime J., Mocarski E.J., Hastings D., et al. Congenital heart disease in pregnancy: short- and long-term implications. Am J Obstet Gynecol 156 2 (1987) 313-322
38. Presbitero P., Somerville J., Stone S., et al. Pregnancy in cyanotic congenital heart disease. Outcome of mother and fetus. Circulation 89 6 (1994) 2673-2676
39. Saidi A.S., Bezold L.I., Altman C.A., et al. Outcome of pregnancy following intervention for coarctation of the aorta. Am J Cardiol 82 6 (1998) 786-788
40. Beauchesne L.M., Connolly H.M., Ammash N.M., et al. Coarctation of the aorta: outcome of pregnancy. J Am Coll Cardiol 38 6 (2001) 1728-1733
41. Wood P. The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt. Br Med J 46 5099 (1958) 755-762
42. Weiss B.M., Zemp L., Seifert B., et al. Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. J Am Coll Cardiol 31 7 (1998) 1650-1657
43. Lacassie H.J., Germain A.M., Valdes G., et al. Management of Eisenmenger syndrome in pregnancy with sildenafil and L-arginine. Obstet Gynecol 103 5 Pt 2 (2004) 1118-1120
44. Geohas C., and McLaughlin V.V. Successful management of pregnancy in a patient with Eisenmenger syndrome with epoprostenol. Chest 124 3 (2003) 1170-1173
45. Goodwin T.M., Gherman R.B., Hameed A., et al. Favorable response of Eisenmenger syndrome to inhaled nitric oxide during pregnancy. Am J Obstet Gynecol 180 1 Pt 1 (1999) 64-67
46. Breen T.W., and Janzen J.A. Pulmonary hypertension and cardiomyopathy: anaesthetic management for caesarean section. Can J Anaesth 38 7 (1991) 895-899
47. Beauchesne L.M., Warnes C.A., Connolly H.M., et al. Prevalence and clinical manifestations of 22q11.2 microdeletion in adults with selected conotruncal anomalies. J Am Coll Cardiol 45 4 (2005) 595-598
48. Veldtman G.R., Connolly H.M., Grogan M., et al. Outcomes of pregnancy in women with tetralogy of Fallot. J Am Coll Cardiol 44 1 (2004) 174-180
49. Lind J., and Wallenburg H.C. The Marfan syndrome and pregnancy: a retrospective study in a Dutch population. Eur J Obstet Gynecol Reprod Biol 98 1 (2001) 28-35
50. Rossiter J.P., Repke J.T., Morales A.J., et al. A prospective longitudinal evaluation of pregnancy in the Marfan syndrome. Am J Obstet Gynecol 173 5 (1995) 1599-1606
51. Sakaguchi M., Kitahara H., Watanabe T., et al. Successful surgical treatment for acute aortic dissection in pregnancy with Marfan's syndrome. Jpn J Thorac Cardiovasc Surg 53 4 (2005) 220-222
52. Autore C., Conte M.R., Piccininno M., et al. Risk associated with pregnancy in hypertrophic cardiomyopathy. J Am Coll Cardiol 40 10 (2002) 1864-1869
53. Shotan A., Ostrzega E., Mehra A., et al. Incidence of arrhythmias in normal pregnancy and relation to palpitations, dizziness, and syncope. Am J Cardiol 79 8 (1997) 1061-1064
54. Gowda R.M., Khan I.A., Mehta N.J., et al. Cardiac arrhythmias in pregnancy: clinical and therapeutic considerations. Int J Cardiol 88 2-3 (2003) 129-133
55. Page R.L., Hamdan M.H., and Joglar J.A. Arrhythmias occurring during pregnancy. Card Electrophysiol Rev 6 1-2 (2002) 136-139
56. Tan H.L., and Lie K.I. Treatment of tachyarrhythmias during pregnancy and lactation. Eur Heart J 22 6 (2001) 458-464
57. Brown C.E., and Wendel G.D. Cardiac arrhythmias during pregnancy. Clin Obstet Gynecol 32 1 (1989) 89-102
58. Page R.L. Treatment of arrhythmias during pregnancy. Am Heart J 130 4 (1995) 871-876
59. Rashba E.J., Zareba W., Moss A.J., et al., LQTS Investigators. Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome. Circulation 97 5 (1998) 451-456 (10)
60. O'Hare M.F., Murnaghan G.A., Russell C.J., et al. Sotalol as a hypotensive agent in pregnancy. Br J Obstet Gynaecol 87 9 (1980) 814-820
61. Magee L.A., Downar E., Sermer M., et al. Pregnancy outcome after gestational exposure to amiodarone in Canada. Am J Obstet Gynecol 172 4 Pt 1 (1995) 1307-1311
62. Bartalena L., Bogazzi F., Braverman L.E., et al. Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment. J Endocrinol Invest 24 2 (2001) 116-130
63. Luppi C.J. Cardiopulmonary resuscitation: pregnant women are different. AACN Clin Issues 8 4 (1997) 574-585
64. Lampert M.B., and Lang R.M. Peripartum cardiomyopathy. Am Heart J 130 4 (1995) 860-870
65. Cunningham F.G., Pritchard J.A., Hankins G.D., et al. Peripartum heart failure: idiopathic cardiomyopathy or compounding cardiovascular events?. Obstet Gynecol 67 2 (1986) 157-168
66. Demakis J.G., and Rahimtoola S.H. Peripartum cardiomyopathy. Circulation 44 5 (1971) 964-968
67. Lampert M.B., and Lang R.M. Peripartum cardiomyopathy. Am Heart J 130 4 (1995) 860-870
68. Elkayam U., Akhter M.W., Singh H., et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 111 16 (2005) 2050-2055
69. Elkayam U., Tummala P.P., Rao K., et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 344 21 (2001) 1567-1571
70. Chapa J.B., Heiberger H.B., Weinert L., et al. Prognostic value of echocardiography in peripartum cardiomyopathy. Obstet Gynecol 105 6 (2005) 1303-1308
71. Rahimtoola S.H., and Tak T. The use of digitalis in heart failure. Curr Probl Cardiol 21 12 (1996) 781-853
72. Cohn J.N., Archibald D.G., Ziesche S., et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med 314 24 (1986) 1547-1552
73. Hunt S.A., Baker D.W., Chin M.H., et al. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America. Circulation 104 24 (2001) 2996-3007
74. Demakis J.G., Rahimtoola S.H., Sutton G.C., et al. Natural course of peripartum cardiomyopathy. Circulation 44 6 (1971) 1053-1061
75. Felker G.M., Jaeger C.J., Klodas E., et al. Myocarditis and long-term survival in peripartum cardiomyopathy. Am Heart J 140 5 (2000) 785-791
76. Roth A., and Elkayam U. Acute myocardial infarction associated with pregnancy. Ann Intern Med 125 9 (1996) 751-762
77. Ladner H.E., Danielsen B., and Gilbert W.M. Acute myocardial infarction in pregnancy and the puerperium: a population-based study. Obstet Gynecol 105 3 (2005) 480-484
78. Iadanza A., Del P.A., Barbati R., et al. Acute ST elevation myocardial infarction in pregnancy due to coronary vasospasm: a case report and review of literature. Int J Cardiol 115 1 (2006) 81-85
79. James A.H., Jamison M.G., Biswas M.S., et al. Acute myocardial infarction in pregnancy: a United States population-based study. Circulation 113 12 (2006) 1564-1571
80. Shade Jr. G.H., Ross G., Bever F.N., et al. Troponin I in the diagnosis of acute myocardial infarction in pregnancy, labor, and post partum. Am J Obstet Gynecol 187 6 (2002) 1719-1720
81. Ascarelli M.H., Grider A.R., and Hsu H.W. Acute myocardial infarction during pregnancy managed with immediate percutaneous transluminal coronary angioplasty. Obstet Gynecol 88 4 Pt 2 (1996) 655-657
82. Fleyfel M., Bourzoufi K., Huin G., et al. Recombinant tissue type plasminogen activator treatment of thrombosed mitral valve prosthesis during pregnancy. Can J Anaesth 44 7 (1997) 735-738
83. Usta I.M., Abdallah M., El Hajj M., et al. Massive subchorionic hematomas following thrombolytic therapy in pregnancy. Obstet Gynecol 103 5 Pt 2 (2004) 1079-1082
84. Webber M.D., Halligan R.E., and Schumacher J.A. Acute infarction, intracoronary thrombolysis, and primary PTCA in pregnancy. Cathet Cardiovasc Diagn 42 1 (1997) 38-43
85. Togni M., Amann F.W., and Follath F. Spontaneous multivessel coronary artery dissection in a pregnant woman treated successfully with stent implantation. Am J Med 107 4 (1999) 407-408
86. Parry A.J., and Westaby S. Cardiopulmonary bypass during pregnancy. Ann Thorac Surg 61 6 (1996) 1865-1869
87. Bernal J.M., and Miralles P.J. Cardiac surgery with cardiopulmonary bypass during pregnancy. Obstet Gynecol Surv 41 1 (1986) 1-6
88. Strickland R.A., Oliver Jr. W.C., Chantigian R.C., et al. Anesthesia, cardiopulmonary bypass, and the pregnant patient. Mayo Clin Proc 66 4 (1991) 411-429
89. Pomini F., Mercogliano D., Cavalletti C., et al. Cardiopulmonary bypass in pregnancy. Ann Thorac Surg 61 1 (1996) 259-268
90. Mahli A., Izdes S., and Coskun D. Cardiac operations during pregnancy: review of factors influencing fetal outcome. Ann Thorac Surg 69 5 (2000) 1622-1626
91. North R.A., Sadler L., Stewart A.W., et al. Long-term survival and valve-related complications in young women with cardiac valve replacements. Circulation 99 20 (1999) 2669-2676
92. Jamieson W.R., Miller D.C., Akins C.W., et al. Pregnancy and bioprostheses: influence on structural valve deterioration. Ann Thorac Surg 60 suppl 2 (1995) S282-S286
93. Salazar E., Espinola N., Roman L., et al. Effect of pregnancy on the duration of bovine pericardial bioprostheses. Am Heart J 137 4 Pt 1 (1999) 714-720
94. Hall J.G., Pauli R.M., and Wilson K.M. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 68 1 (1980) 122-140
95. Vitale N., De Feo M., De Santo L.S., et al. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 33 6 (1999) 1637-1641
96. Hirsh J., Fuster V., Ansell J., et al. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. J Am Coll Cardiol 41 9 (2003) 1633-1652
97. Sbarouni E., and Oakley C.M. Outcome of pregnancy in women with valve prostheses. Br Heart J 71 2 (1994) 196-201
98. Iturbe-Alessio I., Fonseca M.C., Mutchinik O., et al. Risks of anticoagulant therapy in pregnant women with artificial heart valves. N Engl J Med 315 22 (1986) 1390-1393 (27)
99. Hanania G. Management of anticoagulants during pregnancy. Heart 86 2 (2001) 125-126
100. Pitkin R.M., Perloff J.K., Koos B.J., et al. Pregnancy and congenital heart disease. Ann Intern Med 112 6 (1990) 445-454
101. Canobbio M.M., Mair D.D., van der Velde, et al. Pregnancy outcomes after the Fontan repair. J Am Coll Cardiol 28 3 (1996) 763-767
102. Drenthen W., Pieper P.G., Roos-Hesselink J.W., et al. Pregnancy and delivery in women after Fontan palliation. Heart 92 9 (2006) 1290-1294
103. Gerardin B., Houyel L., Discazeaux B., et al. [Successful pregnancy after Fontan procedure complicated by recurrent junctional tachycardia]. Arch Mal Coeur Vaiss 86 6 (1993) 935-938
104. Ito M., Takagi N., Sugimoto S., et al. Pregnancy after undergoing the Fontan procedure for a double outlet right ventricle: report of a case. Surg Today 32 1 (2002) 63-65
105. Singh H., Bolton P.J., and Oakley C.M. Pregnancy after surgical correction of tetralogy of Fallot. Br Med J (Clin Res Ed) 285 6336 (1982) 168-170
106. Clarkson P.M., Wilson N.J., Neutze J.M., et al. Outcome of pregnancy after the Mustard operation for transposition of the great arteries with intact ventricular septum. J Am Coll Cardiol 24 1 (1994) 190-193
107. Lowenstein B.R., Vain N.W., Perrone S.V., et al. Successful pregnancy and vaginal delivery after heart transplantation. Am J Obstet Gynecol 158 3 Pt 1 (1988) 589-590
108. Miller L.W., Labovitz A.J., McBride L.A., et al. Echocardiography-guided endomyocardial biopsy. A 5-year experience. Circulation 78 5 Pt 2 (1988) III99-III102
109. Scott J.R., Wagoner L.E., Olsen S.L., et al. Pregnancy in heart transplant recipients: management and outcome. Obstet Gynecol 82 3 (1993) 324-327
110. Baxi L.V., and Rho R.B. Pregnancy after cardiac transplantation. Am J Obstet Gynecol 169 1 (1993) 33-34 (July)
111. Laifer S.A., Yeagley C.J., and Armitage J.M. Pregnancy after cardiac transplantation. Am J Perinatol 11 3 (1994) 217-219
112. Alper M.H., and Roaf E.R. Anesthetic management of the high-risk pregnancy. Clin Obstet Gynecol 16 1 (1973) 347-360
113. Bonica J.J. Obstetric analgesia and anesthesia. Recent trends and advances. NY State J Med 70 16 (1970) 2079-2084 (15)
114. Malinow A.M., and Ostheimer G.W. Anesthesia for the high-risk parturient. Obstet Gynecol 69 6 (1987) 951-964
115. Mitterschiffthaler G. Regional anesthesia for the pregnant cardiac patient. Acta Anaesthesiol Scand Suppl 109 (1996) 180-184
116. Copel J.A., Harrison D., Whittemore R., et al. Intrathecal morphine analgesia for vaginal delivery in a woman with a single ventricle. A case report. J Reprod Med 31 4 (1986) 274-276
117. Schabel J.E., and Jasiewicz R.C. Anesthetic management of a pregnant patient with congenitally corrected transposition of the great arteries for labor and vaginal delivery. J Clin Anesth 13 7 (2001) 517-520
118. Mitani G.M., Steinberg I., Lien E.J., et al. The pharmacokinetics of antiarrhythmic agents in pregnancy and lactation. Clin Pharmacokinet 12 4 (1987) 253-291
119. Rotmensch H.H., Rotmensch S., and Elkayam U. Management of cardiac arrhythmias during pregnancy. Current concepts. Drugs 33 6 (1987) 623-633
120. Chan V., Tse T.F., and Wong V. Transfer of digoxin across the placenta and into breast milk. Br J Obstet Gynaecol 85 8 (1978) 605-609
121. Pruyn S.C., Phelan J.P., and Buchanan G.C. Long-term propranolol therapy in pregnancy: maternal and fetal outcome. Am J Obstet Gynecol 135 4 (1979) 485-489
122. Barden T.P., and Stander R.W. Effects of adrenergic blocking agents and catecholamines in human pregnancy. Am J Obstet Gynecol 102 2 (1968) 226-235
123. Wadworth A.N., Murdoch D., and Brogden R.N. Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders. Drugs 42 3 (1991) 468-510
124. Mason B.A., Ricci-Goodman J., and Koos B.J. Adenosine in the treatment of maternal paroxysmal supraventricular tachycardia. Obstet Gynecol 80 (1992) 478-480
125. Ferencz C., Rubin J.D., Mc Carter R.J., et al. Congenital heart disease: prevalence at live birth. The Baltimore-Washington Infant Study. Am J Epidemiol 121 (1985) 31-36
126. Chervenak F.A., and McCullough L.B. Perinatal ethics: a practical method of analysis of obligations to mother and fetus. Obstet Gynecol 66 (1985) 442-446
127. American Academy of Pediatrics Committee on Bioethics. Fetal therapy: ethical considerations. Pediatrics 81 (1988) 898-899
128. Copel J.A., Pilu G., and Kleinman C.S. Congenital heart disease and extracardiac anomalies: associations and indications for fetal echocardiography. Am J Obstet Gynecol 154 (1986) 1121-1132
129. Copel J.A., Pilu G., and Kleinman C.S. Extracardiac anomalies and congenital heart disease. Sem Perinatol 17 (1993) 89-105
130. DeVore G.R. Trisomy 21: 91% detection rate using second-trimestser ultrasound markers. Ultrasound Obstet Gynecol 16 (2000) 133-141
131. Buyon J.P., Clancey R., Di Donato F., et al. Cardiac 5-HT serotoninergic receptors, 52KD SSA/Ro and autoimmune-associated congenital heart block. J Autoimmun 19 (2002) 79-86
132. Schmidt L.G., Ulmer H.E., Silverman N.H., et al. Perinatal outcome of fetal complete atrioventricular block: a multicenter experience. J Am Coll Cardiol 91 (1991) 1360-1366
133. Cooley W.C., and Graham Jr. J.M. Down syndrome-an update and review for the primary pediatrician. Clin Pediatr 30 (1991) 233-253
134. Botto L.D., May K., Fernhoff P.M., et al. A population-based study of the 22ql1.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 112 (2003) 101-107
135. Cuneo B.F., and Strasburger J.F. Management strategy for fetal tachycardia. Obstet Gynecol 96 (2000) 575-581
136. Sklansky M., Greenberg M., Lucas V., et al. Intrapericardial teratoma in a twin fetus: diagnosis and management. Obstet Gynecol 89 (1997) 807-809
137. Tworetzky W., Wilkins-Haug L., Jennings R.W., et al. Balloon dilation of severe aortic stenosis in the fetus. Circulation 11 (2004) 2125-1
138. Reddy V.M., Liddicoat J.R., Klein J.R., et al. Long-term fetal outcome after fetal cardiac bypass: fetal survival to full term and organ abnormalities. J Thorac Cardiovasc Surg 111 (1996) 536-544
139. Rychik J., Tian Z., Cohen M.S., et al. Acute cardiovascular effects of fetal surgery in the human. Circulation 110 (2004) 1549-1556
140. Harrison M.R. Fetal surgery. Am J Obstet Gynecol 174 (1996) 1255-1264
141. Kovalchin J.P., and Silverman N.H. The impact of fetal echocardiography. Pediatr Cardiol 25 (2004) 299-306
142. Bonnet D., Coltri A., Butera G., et al. Detection of transposition of the great arteries in fetuses reduces neonatal morbidity and mortality. Circulation 99 (1999) 916-918
143. Chang A.C., Huhta J.C., Yoon G.Y., et al. Diagnosis, transport, and outcome in fetuses with left ventricular outflow tract obstruction. J Thorac Cardiovasc Surg 102 (1991) 841-848
144. Franklin O., Burch M., Manning N., et al. Prenatal diagnosis of coarctation of the aorta improves survival and reduces morbidity. Heart 87 (2002) 67-69
145. Verheijen P.M., Lisowski L.A., Stoutenbeek P., et al. Prenatal diagnosis of congenital heart disease affects preoperative acidosis in the newborn infant. J Thorac Cardiovasc Surg 121 (2001) 798-803
146. Kumar R.K., Newburger J.W., Gauvreau K., et al. Comparison of outcome when hypoplastic left heart syndrome and transposition of the great arteries are diagnosed prenatally versus when diagnosis of these two conditions is made only postnatally. Am J Cardiol 83 (1999) 1649-1653
147. Montana E., Khoury M.J., Cragan J.D., et al. Trends and outcomes after prenatal diagnosis of congenital cardiac malformations by fetal echocardiography in a well defined birth population, Atlanta, Georgia, 1990-1994. J Am Coll Cardiol 28 (1996) 1805-1809
148. Sklansky M., Tang A., Levy D., et al. Maternal psychological impact of fetal echocardiography. J Am Soc Echocardiogr 15 (2002) 159-166
149. Carmichael S., and Shaw G. Maternal life event stress and congenital anomalies. Epidemiology 11 (2000) 30-35
150. Hansen D., Lou H., and Olsen J. Serious life events and congenital malformations: a national study with complete follow-up. Lancet 356 (2000) 875-880
151. Allan L.D., Cook A., Sullivan I., et al. Hypoplastic left heart syndrome: effects of fetal echocardiography on birth prevalence. Lancet 337 (1991) 959-961
152. Daubeney P.E., Sharland G.K., Cook A.C., et al. Pulmonary atresia with intact ventricular septum: impact of fetal echocardiography on incidence at birth and postnatal outcome. UK and Eire Collaborative Study of Pulmonary Atresia with Intact Ventricular Septum. Circulation 98 (1998) 562-566
153. Bull Catherine for the British Paediatric Cardiac Association. Current and potential impact of fetal diagnosis on prevalence and spectrum of serious congenital heart disease at term in the UK. Lancet 354 (1999) 1242-1247
154. Small M., and Copel J.A. Indications for fetal echocardiography. Pediatr Cardiol 25 (2004) 210-222
155. Buskens E., Grobbee D.E., Frohn-Mulder I.M., et al. Efficacy of routine fetal ultrasound screening for congenital heart disease in normal pregnancy. Circulation 94 (1996) 67-72
156. LeFevre M.L., Bain R.P., Ewigman B.G., et al., RADIUS (Routine Antenatal Diagnostic Imaging with Ultrasound) Study Group. A randomized trial of prenatal ultrasonographic screening: impact on maternal management and outcome. Am J Obstet Gynecol 169 (1993) 483-489
157. Tegnander E., Eik-Nes S.H., Johansen O.J., et al. Prenatal dectection of heart defects at the routine fetal examination at 18 weeks in a non-selected population. Ultrasound Obstet Gynecol 5 (1995) 373-380
158. Allan L.D., Chita S.K., Sharland G.K., et al. The accuracy of fetal echocardiography in the diagnosis of congenital heart disease. Int J Cardiol 25 (1989) 279-288
159. Davis G.K., Farquhar C.M., Allan L.D., et al. Structural cardiac abnormalities in the fetus: reliability of prenatal diagnosis and outcome. Br J Obstet Gynecol 97 (1990) 27-31
160. Meyer-Wittkopf M., Cooper S., and Sholler G. Correlation between fetal cardiac diagnosis by obstetric and pediatric cardiologist sonographers and comparison with postnatal findings. Ultrasound Obstet Gynecol 17 (2001) 392-397
161. Stumfplen I., Stumfplen A., Wimmer M., et al. Effect of detailed fetal echocardiography as part of routine prenatal ultrasonographic screening on detection of congenital heart disease. Lancet 348 (1996) 854-857
162. Hyett J.A., Moscosco G., Papanagiotou G., et al. Abnormalities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 11-13 weeks of gestation. Ultrasound Obstet Gynecol 7 (1996) 245-250
163. Hyett J., Perdu M., Sharland G., et al. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study. BMJ 318 (1999) 81-85
164. Allan L.D., Crawford D.C., Chita S.K., et al. Familial recurrence of congenital heart disease in a prospective series of mothers referred for fetal echocardiography. Am J Cardiol 58 (1986) 334-337
165. Boughman J.A., Berg K.A., Astemborski J.A., et al. Familial risks of congenital heart defect in a population-based epidemiological study. Am J Med Genet 26 (1987) 839-849
166. Nora J.J., and Nora A.H. Maternal transmission of congenital heart diseases: new recurrence risk figures and the questions of cytoplasmic inheritance and vulnerability to teratogens. Am J Cardiol 59 (1987) 459-463
167. Rowland T.W., Hubbell Jr. J.P., and Nadas A.S. Congenital heart disease in infants of diabetic mothers. J Pediatr 83 (1973) 815-820
168. Miller E., Hare J.W., Cloherty J.P., et al. Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med 302 (1981) 1331-1334
169. Becerra J.E., Khoury M.J., Cordero J.F., et al. Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case control study. Pediatrics 85 (1990) 1-9
170. Zierler S. Maternal drugs and congenital heart disease. Obstet Gynecol 65 (1985) 155-165
171. Zierler S., and Rothman K.J. Congenital heart disease in relation to maternal use of Bendictin and other drugs in early pregnancy. N Engl J Med 313 (1985) 347-352
172. Burn J., Brennan P., Little J., et al. Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study. Lancet 351 (1998) 311-316
173. Gill H.K., Splitt M., Sharland G.K., et al. Patterns of recurrence of congenital heart disease. An analysis of 6,640 consecutive pregnancies evaluated by detailed fetal echocardiography. J Am Coll Cardiol 42 (2003) 923-929
174. Ott W.J. The accuracy of antenatal fetal echocardiography screening in high- and low-risk patients. Am J Obstet Gynecol 172 (1995) 1741-1749
175. Ewigman B.G., Crane J.P., Frigoletto F.D., et al. Effect of prenatal ultrasound screening on perinatal outcome. N Engl J Med 329 (1993) 821-827
176. Copel J.A., Pilu G., Green J., et al. Fetal echocardiographic screening for congenital heart disease: the importance of the four chamber view. Am J Obstet Gynecol 157 (1987) 648-5
177. Vergani P., Mariani S., Ghidini A., et al. Screening for congenital heart disease with the four-chamber view of the fetal heart. Am J Obstet Gynecol 167 (1992) 1000-1003
178. Achiron R., Glaser J., Gelernter I., et al. Extended fetal echocardiographic examination for detecting cardiac malformations in low risk pregnancies. BMJ 304 (1992) 671-674
179. Kirk J.S., Riggs T.W., Comstock C.H., et al. Prenatal screening for cardiac anomalies: the value of routine addition of the aortic root to the four-chamber view. Obstet Gynecol 84 (1994) 427-431
180. Bromley B., Estroff J.A., Sanders S.P., et al. Fetal echocardiography: accuracy and limitations in a population at high and low risk for heart defects. Am J Obstet Gynecol 166 (1992) 1473-1481
181. Haak M.C., Twisk J.W., and Van Vugt J.M. How successful is fetal echocardiographic examination in the first trimester of pregnancy?. Ultrasound Obstet Gynecol 20 (2002) 9-13
182. Huggon I.C., Ghi T., Cook A.C., et al. Fetal cardiac abnormalities identified prior to 14 weeks gestation. Ultrasound Obstet Gynecol 20 (2002) 22-27
183. Allan L.D., Santos R., and Pexieder T. Anatomical and echocardiographic correlates of normal cardiac morphology in the late first trimester fetus. Heart 77 (1997) 68-72
184. Carvalho J.S., Moscoso G., Tekay A., et al. Clinical impact of first and early second trimester fetal echocardiography on high risk pregnancies. Heart 90 (2004) 921-926
185. Haak M., and Van Vugt J.M.G. Echocardiography in early pregnancy. Review of literature. J Ultrasound Med 22 (2003) 271-280
186. Danford D.A., and Cronican P. Hypoplastic left heart syndrome: progression of left ventricular dilation and dysfunction to left ventricular hypoplasia in utero. Am Heart J 123 (1992) 1712-1713
187. Trines J., and Hornberger L.K. Evolution of heart disease in utero. Pediatr Cardiol 25 (2004) 287-298
188. Hornberger L.K., Sanders S.P., Rein A.J., et al. Left heart obstructive lesions and left ventricular growth in the midtrimester fetus. A longitudinal study. Circulation 92 (1995) 1531-1538
189. Hornberger L.K., Sanders S.P., Sahn D.J., et al. In utero pulmonary artery and aortic growth and potential for progression of pulmonary outflow tract obstruction in tetralogy of Fallot. J Am Coll Cardiol 25 (1995) 739-749
190. DeVore G.R., Donnerstein R.L., Kleinman C.S., et al. Fetal echocardiography. I. Normal anatomy as determined by real-time-directed M-mode ultrasound. Am J Obstet Gynecol 144 (1982) 249-260
191. Allan L.D., Tynan M.J., Campbell S., et al. Echocardiographic and anatomical correlates in the fetus. Br Heart J 44 (1980) 444-451
192. Sahn D.J., Lange L.W., Allen H.D., et al. Quantitative real-time cross-sectional echocardiography in the developing normal human fetus and newborn. Circulation 62 (1980) 588-597
193. Allan L. Technique of fetal echocardiography. Pediatr Cardiol 25 (2004) 223-233
194. Allan L. The normal fetal heart. In: Allan L., Hornberger L., and Sharland G. (Eds). Textbook of fetal cardiology (2000), Greenwich Medical Media, London, England 55-102
195. Respondek M., Kammermeier M., Ludomirsky A., et al. The prevalence and clinical significance of fetal tricuspid valve regurgitation with normal heart anatomy. Am J Obstet Gynecol 171 (1994) 1265-1270
196. Huhta J.C. Future directions in noninvasive Doppler evaluation of the fetal circulation. Cardiol Clin 7 (1989) 239-253
197. Tulzer G., Gudmundsson S., Sharkey A.M., et al. Doppler echocardiography of fetal ductus arteriosus constriction versus increased right ventricular output. J Am Coll Cardiol 18 (1991) 532-536
198. Sklansky M.S., DeVore G.R., and Wong P.C. Real-time 3-dimensional fetal echocardiography with an instantaneous volume-rendered display. Early description and pictorial essay. J Ultrasound Med 23 (2004) 283-289
199. Sklansky M.S., Nelson T.R., and Pretorius D.H. Usefulness of gated three-dimensional fetal echocardiography to reconstruct and display structures not visualized with two-dimensional imaging. Am J Cardiol 80 (1997) 665-668
200. Sklansky M.S., Nelson T., Strachan M., et al. Real-time three-dimensional fetal echocardiography: initial feasibility study. J Ultrasound Med 18 (1999) 745-752
201. Schindera S.T., Mehwald P.S., Sahn D.J., et al. Accuracy of real-time three-dimensional echocardiography for quantifying right ventricular volume. J Ultrasound Med 21 (2002) 1069-1975
202. Meyer-Wittkopf M., Cole A., Cooper S.G., et al. Three-dimensional quantitative echocardiographic assessment of ventricular volume in healthy human fetuses and in fetuses with congenital heart disease. J Ultrasound Med 20 (2001) 317-327
203. Goncalves L.F., Romero R., Espinoza J., et al. Four-dimensional ultrasonography of the fetal heart using color Doppler spatiotemporal image correlation. J Ultrasound Med 23 (2004) 473-481
204. Deng J., Sullivan I.D., Yates R., et al. Real-time three-dimensional fetal echocardiography: optimal imaging windows. Ultrasound Med Biol 28 (2002) 1099-1105
205. DeVore G.R., Falkensammer P., Sklansky M.S., et al. Spatio-temporal image correlation (STIC): a new technology for evaluation of the fetal heart. Ultrasound Obstet Gynecol 22 (2003) 380-387
206. Michailidis G.C., Simpson J.M., Karidas C., et al. Detailed three-dimensional fetal echocardiography facilitated by an internet link. Ultrasound Obstet Gynecol 18 (2001) 325-328
207. Nelson T.R., Pretorius D.H., Sklansky M., et al. Three-dimensional echocardiographic evaluation of fetal heart anatomy and function: acquisition, analysis and display. J Ultrasound Med 15 (1996) 1-9
208. Rychik J., Ayres N., Cuneo B., et al., Pediatric Council of the American Society of Echocardiography. American Society of Echocardiogrphy guidelines and standards for performance of the fetal echocardiogram. J Am Soc Echocardiogr 17 (2004) 803-810
209. Quinones M.A., Douglas P.S., Foster E., et al. ACC/AHA clinical competence statement on echocardiography. A report of the American College of Cardiology/American Heart Association/American College of Physicians-American Society of Internal Medicine task force on clinical competence. J Am Coll Cardiol 41 (2003) 687-708
210. Huhta J.C. Right ventricular function in the human fetus. J Perinat Med 29 (2001) 381-389
211. Huhta J.C. Guidelines for the evaluation of heart failure in the fetus with or without hydrops. Pediatr Cardiol 25 (2004) 274-286
212. Hecher K., Campbell S., Doyle P., et al. Assessment of fetal compromise by Doppler ultrasound investigation of the fetal circulation. Circulation 91 (1995) 129-138
213. Harada K., Rice M.J., McDonald R.W., et al. Doppler echocardiographic evaluation of ventricular diastolic filling in fetuses with ductal constriction. Am J Cardiol 79 (1997) 442-446
214. Kleinman C.S., and Nehgme R.A. Cardiac arrhythmias in the human fetus. Pediatr Cardiol 25 (2004) 234-251
215. Respondek M., Wloch A., Kaczmarek P., et al. Diagnostic and perinatal management of fetal extrasystole. Pediatr Cardiol 18 (1997) 361-366
216. Hofbeck M., Ulmer H., Beinder E., et al. Prenatal findings in patients with prolonged QT interval in the neonatal period. Heart 77 (1997) 198-204
217. Buyon J.P., Hiebert R., Copel J.A., et al. Autoimmune-associated congenital heart block: mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 31 (1998) 1658-1666
218. Nield L.E., Silverman E.D., Smallhorn J.F., et al. Endocardial fibroelastosis associated with maternal anti-Ro and anti-La antibodies in the absence of atrioventricular block. J Am Coll Cardiol 40 (2002) 796-802
219. Jaeggi E.T., Fouron J.C., Silverman E.D., et al. Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease. Circulation 110 (2004) 1542-1548
220. Simpson L.L., Marx G.R., and D'Alton M.E. Supraventricular tachycardia in the fetus: conservative management in the absence of hemodynamic compromise. J Ultrasound Med 16 (1997) 459-464
221. Kleinman C.S., Copel J.A., Weinstein E.M., et al. In utero diagnosis and treatment of fetal supraventricular tachycardia. Sem Perinatol 9 (1985) 113-129
222. Oudijk M.A., Michon M.M., Kleinman C.S., et al. Sotalol in the treatment of fetal dysrhythmias. Circulation 101 (2000) 2721-2726
223. Rychik J.F. Fetal cardiovascular physiology. Pediatr Cardiol 25 (2004) 201-209
224. Marshall A.C., van der Velde M.E., Tworetzky W., et al. Creation of an atrial septal defect in utero for fetuses with hypoplastic left heart syndrome and intact or highly restrictive atrial septum. Circulation 110 (2004) 253-258